doi: 10.1111/febs.13698
For many of my patients with obesity and sleep apnea, sustained weight loss means better breathing at night, lower blood pressure, fewer medications and more energy
Starting at too high of a dose or increasing the dose too quickly can lead to symptoms such as indigestion, nausea, vomiting, diarrhea, or constipation
The consequences extend beyond slowed weight loss
Eur J Clin Pharmacol 80:669676 King AC, McNamara PJ, Hasin DS, Cao D (2014) Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study
The Takeaway While both Novo and Lilly have multi-year regulatory head-starts and are now rapidly becoming part of the zeitgeist around treating obesity, Regenerons angle of addressing muscle loss could help set it apart from other GLP-1 hopefuls and even incumbents by leading to improved long-term outcomes.